Accretion Nutraveda Limited (BOM:544694)

India · Delayed Price · Currency is INR

261.50

0.00 (0.00%)

At close: May 29, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Manufacturing and Sale of Pharmaceutical Products	337.16M	160.49M	50.69M	30.03M	5.85M
Manufacturing and Sale of Pharmaceutical Products Growth	110.07%	216.62%	68.81%	413.23%	-
Total	337.16M	160.49M	50.69M	30.03M	5.85M
Total Growth	110.07%	216.62%	68.81%	413.23%	-

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
India	154.62M	49.12M	28.85M	5.85M
India Growth	214.79%	70.24%	393.16%	-
Export	5.40M	934.00K	178.00K	-
Export Growth	478.27%	424.72%	-	-
Total	160.02M	50.05M	29.03M	5.85M
Total Growth	219.70%	72.41%	396.21%	-

Source: S&P Global Market Intelligence.